InvestorsHub Logo
Followers 156
Posts 6364
Boards Moderated 1
Alias Born 08/06/2004

Re: None

Friday, 02/04/2022 5:11:24 PM

Friday, February 04, 2022 5:11:24 PM

Post# of 462168
ok so just got off the phone with IR. I'm paraphrasing what we both said:
Q: Why do the slides from the JP Morgan conference list it as a phase 2/3 and only RSBQ if it had already been changed to a Phase 3 and to RSBQ-AUC?
A: Phase 2/3 and RSBQ were what was publically known so the company could not present alternate information without releasing it publically before hand.
Q: Then why didn't you do that?
A: There are certain things we wish we had done differently? The changes were made at the request of the FDA.
Q: You are confirming that the FDA directly requested that Anavex change the trial to a Phase 3 and that the endpoints be changed?
A: Yes I can confirm that.

Q: Why on the conference call did Missling talk solely about the FDA guidance and nothing about the UK or Australia, and then on today's press release it was the exact opposite?

From alexrenard07 on ST.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News